Financials

News Ideas Discussions Technicals Forecast Seasonals

CRVS fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Corvus Pharmaceuticals, Inc.

Total assets of CRVS for Q2 24 is 64.56 M USD, 61.06% more than the previous Q1 24. And total liabilities increased by 98.44% in Q2 24 to 13.34 M USD.

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

Q2 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—